Anti-LSR/ ILDR3/ LISCH7 monoclonal antibody

Anti-LSR/ ILDR3/ LISCH7 antibody for FACS & in-vivo assay

Target products collectionGo to LSR/LSR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0774-Ab-1/ GM-Tg-hg-MP0774-Ab-2Anti-Human LSR monoclonal antibodyHuman
GM-Tg-rg-MP0774-Ab-1/ GM-Tg-rg-MP0774-Ab-2Anti-Rat LSR monoclonal antibodyRat
GM-Tg-mg-MP0774-Ab-1/ GM-Tg-mg-MP0774-Ab-2Anti-Mouse LSR monoclonal antibodyMouse
GM-Tg-cynog-MP0774-Ab-1/ GM-Tg-cynog-MP0774-Ab-2Anti-Cynomolgus/ Rhesus macaque LSR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0774-Ab-1/ GM-Tg-felg-MP0774-Ab-2Anti-Feline LSR monoclonal antibodyFeline
GM-Tg-cang-MP0774-Ab-1/ GM-Tg-cang-MP0774-Ab-2Anti-Canine LSR monoclonal antibodyCanine
GM-Tg-bovg-MP0774-Ab-1/ GM-Tg-bovg-MP0774-Ab-2Anti-Bovine LSR monoclonal antibodyBovine
GM-Tg-equg-MP0774-Ab-1/ GM-Tg-equg-MP0774-Ab-2Anti-Equine LSR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0774-Ab-1/ GM-Tg-hg-MP0774-Ab-2; GM-Tg-rg-MP0774-Ab-1/ GM-Tg-rg-MP0774-Ab-2;
GM-Tg-mg-MP0774-Ab-1/ GM-Tg-mg-MP0774-Ab-2; GM-Tg-cynog-MP0774-Ab-1/ GM-Tg-cynog-MP0774-Ab-2;
GM-Tg-felg-MP0774-Ab-1/ GM-Tg-felg-MP0774-Ab-2; GM-Tg-cang-MP0774-Ab-1/ GM-Tg-cang-MP0774-Ab-2;
GM-Tg-bovg-MP0774-Ab-1/ GM-Tg-bovg-MP0774-Ab-2; GM-Tg-equg-MP0774-Ab-1/ GM-Tg-equg-MP0774-Ab-2
Products NameAnti-LSR monoclonal antibody
Formatmab
Target NameLSR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LSR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LSR/ ILDR3/ LISCH7 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000825human LSR Lentivirus plasmid
    ORF Viral VectorvGMLP000825human LSR Lentivirus particle
    ORF Viral VectorpGMLPm005030mouse Lsr Lentivirus plasmid
    ORF Viral VectorvGMLPm005030mouse Lsr Lentivirus particle


    Target information

    Target IDGM-MP0774
    Target NameLSR
    Gene ID51599,54135,64355,106994738,484581,101080849,508651,100059229
    Gene Symbol and SynonymsILDR3,LISCH7,LSR
    Uniprot AccessionQ86X29,Q9WU74
    Uniprot Entry NameLSR_HUMAN,LSR_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105699
    Target ClassificationN/A

    The target: LSR, gene name: LSR, also named as ILDR3, LISCH7. Predicted to be involved in several processes, including establishment of skin barrier; protein localization to tricellular tight junction; and tricellular tight junction assembly. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.